최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Stem cell research & therapy, v.11 no.1, 2020년, pp.209 -
Ju, Younghee (Department of Biological Sciences, KAIST, Daejeon, 34141 Republic of Korea) , Park, Jun Sung (Graduate School of Medical Science and Engineering, KAIST, Daejeon, 34141 Republic of Korea) , Kim, Daejeong (Department of Bio and Brain Engineering, KAIST, Daejeon, 34141 Republic of Korea) , Kim, Bumsoo (Department of Biological Sciences, KAIST, Daejeon, 34141 Republic of Korea) , Lee, Jeong Ho (Graduate School of Medical Science and Engineering, KAIST, Daejeon, 34141 Republic of Korea) , Nam, Yoonkey (Department of Bio and Brain Engineering, KAIST, Daejeon, 34141 Republic of Korea) , Yoo, Han-Wook (Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, 05505 Republic of Korea) , Lee, Beom Hee (Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, 05505 Republic of Korea) , Han, Yong-Mahn (Department of Biological Sciences, KAIST, Daejeon, 34141 Republic of Korea)
BackgroundNoonan syndrome (NS) is a developmental disorder caused by mutations of Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2). Although NS patients have diverse neurological manifestations, the mechanisms underlying the involvement of SHP2 mutations in neurological dysfunc...
1. Mendez HM Opitz JM Noonan syndrome: a review Am J Med Genet 1985 21 3 493 506 3895929
2. Noonan JA Noonan syndrome. An update and review for the primary pediatrician Clin Pediatr 1994 33 9 548 555
3. Roberts AE Allanson JE Tartaglia M Gelb BD Noonan syndrome Lancet. 2013 381 9863 333 342 23312968
4. Tartaglia M Gelb BD Zenker M Noonan syndrome and clinically related disorders Best Pract Res Clin Endocrinol Metab 2011 25 1 161 179 21396583
5. Tartaglia M Mehler EL Goldberg R Zampino G Brunner HG Kremer H Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome Nat Genet 2001 29 4 465 468 11704759
6. Roberts AE Araki T Swanson KD Montgomery KT Schiripo TA Joshi VA Germline gain-of-function mutations in SOS1 cause Noonan syndrome Nat Genet 2007 39 1 70 74 17143285
7. Tartaglia M Pennacchio LA Zhao C Yadav KK Fodale V Sarkozy A Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome Nat Genet 2007 39 1 75 79 17143282
8. Razzaque MA Nishizawa T Komoike Y Yagi H Furutani M Amo R Germline gain-of-function mutations in RAF1 cause Noonan syndrome Nat Genet 2007 39 8 1013 1017 17603482
9. Pandit B Sarkozy A Pennacchio LA Carta C Oishi K Martinelli S Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy Nat Genet 2007 39 8 1007 1012 17603483
10. Aoki Y Niihori T Banjo T Okamoto N Mizuno S Kurosawa K Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome Am J Hum Genet 2013 93 1 173 180 23791108
11. Kouz K Lissewski C Spranger S Mitter D Riess A Lopez-Gonzalez V Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation Genet Med 2016 18 12 1226 1234 27101134
12. Schubbert S Zenker M Rowe SL Boll S Klein C Bollag G Germline KRAS mutations cause Noonan syndrome Nat Genet 2006 38 3 331 336 16474405
13. Carta C Pantaleoni F Bocchinfuso G Stella L Vasta I Sarkozy A Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype Am J Hum Genet 2006 79 1 129 135 16773572
14. Cirstea IC Kutsche K Dvorsky R Gremer L Carta C Horn D A restricted spectrum of NRAS mutations causes Noonan syndrome Nat Genet 2010 42 1 27 29 19966803
15. Motta M Fidan M Bellacchio E Pantaleoni F Schneider-Heieck K Coppola S Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling Hum Mol Genet 2019 28 6 1007 1022 30481304
16. Motta M, Sagi-Dain L, Krumbach OHF, Hahn A, Peleg A, German A, et al. Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy. Hum Mol Genet. 2019:ddz108.10.1093/hmg/ddz108.
17. Higgins EM, Bos JM, Mason-Suares H, Tester DJ, Ackerman JP, MacRae CA, et al. Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy. Jci Insight. 2017;2(5):e91225. 10.1172/jci.insight.91225.
18. Niihori T Nagai K Fujita A Ohashi H Okamoto N Okada S Germline-activating RRAS2 mutations cause Noonan syndrome Am J Hum Genet 2019 104 6 1233 1240 31130285
19. Capri Y Flex E Krumbach OHF Carpentieri G Cecchetti S Lissewski C Activating mutations of RRAS2 are a rare cause of Noonan syndrome Am J Hum Genet 2019 104 6 1223 1232 31130282
20. Tartaglia M Martinelli S Stella L Bocchinfuso G Flex E Cordeddu V Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease Am J Hum Genet 2006 78 2 279 290 16358218
21. Tidyman WE Rauen KA Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway Expert Reviews Mol Med 2008 10 e37
22. Gauthier AS Furstoss O Araki T Chan R Neel BG Kaplan DR Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome Neuron. 2007 54 2 245 262 17442246
23. Ehrman LA Nardini D Ehrman S Rizvi TA Gulick J Krenz M The protein tyrosine phosphatase Shp2 is required for the generation of oligodendrocyte progenitor cells and myelination in the mouse telencephalon J Neurosci 2014 34 10 3767 3778 24599474
24. Zhu Y Park J Hu X Zheng K Li H Cao Q Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase Glia. 2010 58 12 1407 1414 20648636
25. Lee YS Ehninger D Zhou M Oh JY Kang M Kwak C Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome Nat Neurosci 2014 17 12 1736 1743 25383899
26. McWilliams GD SantaCruz K Hart B Clericuzio C Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy Am J Med Genet A 2016 170A 1 195 201 26377682
27. Siegfried A Cances C Denuelle M Loukh N Tauber M Cave H Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature Am J Med Genet A 2017 173 4 1061 1065 28328117
28. El-Ayadi M Ansari M Kuhnol CD Bendel A Sturm D Pietsch T Occurrence of high-grade glioma in Noonan syndrome: report of two cases Pediatr Blood Cancer 2019 66 5 e27625 30693642
29. Alfieri P Piccini G Caciolo C Perrino F Gambardella ML Mallardi M Behavioral profile in RASopathies Am J Med Genet A 2014 164A 4 934 942 24458522
30. Lee DA Portnoy S Hill P Gillberg C Patton MA Psychological profile of children with Noonan syndrome Dev Med Child Neurol 2005 47 1 35 38 15686287
31. Pierpont EI Pierpont ME Mendelsohn NJ Roberts AE Tworog-Dube E Seidenberg MS Genotype differences in cognitive functioning in Noonan syndrome Genes Brain Behav 2009 8 3 275 282 19077116
32. Pierpont EI Pierpont ME Mendelsohn NJ Roberts AE Tworog-Dube E Rauen KA Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome Am J Med Genet A 2010 152A 3 591 600 20186801
33. Wingbermuhle E Egger JI Verhoeven WM van der Burgt I Kessels RP Affective functioning and social cognition in Noonan syndrome Psychol Med 2012 42 2 419 426 21740625
34. Adviento B Corbin IL Widjaja F Desachy G Enrique N Rosser T Autism traits in the RASopathies J Med Genet 2014 51 1 10 20 24101678
35. Alfieri P Cesarini L Mallardi M Piccini G Caciolo C Leoni C Long term memory profile of disorders associated with dysregulation of the RAS-MAPK signaling cascade Behav Genet 2011 41 3 423 429 21274610
36. Tajan M Paccoud R Branka S Edouard T Yart A The RASopathy family: consequences of germline activation of the RAS/MAPK pathway Endocr Rev 2018 39 5 676 700 29924299
37. Rooney GE Goodwin AF Depeille P Sharir A Schofield CM Yeh E Human iPS cell-derived neurons uncover the impact of increased Ras signaling in Costello syndrome J Neurosci 2016 36 1 142 152 26740656
38. Yeh E Dao DQ Wu ZY Kandalam SM Camacho FM Tom C Patient-derived iPSCs show premature neural differentiation and neuron type-specific phenotypes relevant to neurodevelopment Mol Psychiatry 2018 23 8 1687 1698 29158583
39. Krencik R, Hokanson KC, Narayan AR, Dvornik J, Rooney GE, Rauen KA, et al. Dysregulation of astrocyte extracellular signaling in Costello syndrome. Sci Transl Med. 2015;7(286):286ra66. 10.1126/scitranslmed.aaa5645.
40. Han KM Kim SK Kim D Choi JY Im I Hwang KS Enhanced SMAD1 signaling contributes to impairments of early development in CFC-iPSCs Stem Cells 2015 33 5 1447 1455 25639853
41. Centeno EGZ Cimarosti H Bithell A 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling Mol Neurodegener 2018 13 1 27 29788997
42. Lancaster MA Renner M Martin CA Wenzel D Bicknell LS Hurles ME Cerebral organoids model human brain development and microcephaly Nature. 2013 501 7467 373 379 23995685
43. Pasca AM Sloan SA Clarke LE Tian Y Makinson CD Huber N Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture Nat Methods 2015 12 7 671 678 26005811
44. Yakoub AM Sadek M Development and characterization of human cerebral organoids: an optimized protocol Cell Transplant 2018 27 3 393 406 29749250
45. Renner M Lancaster MA Bian S Choi H Ku T Peer A Self-organized developmental patterning and differentiation in cerebral organoids EMBO J 2017 36 10 1316 1329 28283582
46. Trujillo CA Muotri AR Brain organoids and the study of neurodevelopment Trends Mol Med 2018 24 12 982 990 30377071
47. Takahashi K Tanabe K Ohnuki M Narita M Ichisaka T Tomoda K Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell. 2007 131 5 861 872 18035408
48. Kim D Choi J Han KM Lee BH Choi JH Yoo HW Impaired osteogenesis in Menkes disease-derived induced pluripotent stem cells Stem Cell Res Ther 2015 6 160 26347346
49. Kim DS Lee JS Leem JW Huh YJ Kim JY Kim HS Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity Stem Cell Rev 2010 6 2 270 281
50. Shi Y Kirwan P Livesey FJ Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks Nat Protoc 2012 7 10 1836 1846 22976355
51. Yuan SH Martin J Elia J Flippin J Paramban RI Hefferan MP Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells PLoS One 2011 6 3 e17540 21407814
52. Samuels IS Saitta SC Landreth GE MAP’ing CNS development and cognition: an ERKsome process Neuron. 2009 61 2 160 167 19186160
53. Sapir T Frotscher M Levy T Mandelkow EM Reiner O Tau’s role in the developing brain: implications for intellectual disability Hum Mol Genet 2012 21 8 1681 1692 22194194
54. Wang Y Mandelkow E Tau in physiology and pathology Nat Rev Neurosci 2016 17 1 5 21 26631930
55. Tang TL Freeman RM Jr O'Reilly AM Neel BG Sokol SY The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development Cell. 1995 80 3 473 483 7859288
56. Feng GS Shp2-mediated molecular signaling in control of embryonic stem cell self-renewal and differentiation Cell Res 2007 17 1 37 41 17211446
57. Wu D Pang Y Ke Y Yu J He Z Tautz L A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase PLoS One 2009 4 3 e4914 19290061
58. Chambers SM Fasano CA Papapetrou EP Tomishima M Sadelain M Studer L Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat Biotechnol 2009 27 3 275 280 19252484
59. Bernardo AS Faial T Gardner L Niakan KK Ortmann D Senner CE BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages Cell Stem Cell 2011 9 2 144 155 21816365
60. Singh AM Reynolds D Cliff T Ohtsuka S Mattheyses AL Sun Y Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation Cell Stem Cell 2012 10 3 312 326 22385658
61. Fei T Zhu S Xia K Zhang J Li Z Han JD Smad2 mediates Activin/nodal signaling in mesendoderm differentiation of mouse embryonic stem cells Cell Res 2010 20 12 1306 1318 21079647
62. Ke Y Zhang EE Hagihara K Wu D Pang Y Klein R Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality Mol Cell Biol 2007 27 19 6706 6717 17646384
63. Zheng H, Yu WM, Waclaw RR, Kontaridis MI, Neel BG, Qu CK. Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner. Sci Signal. 2018;11(522):eaao1591. 10.1126/scisignal.aao1591.
64. Paquin A Hordo C Kaplan DR Miller FD Costello syndrome H-Ras alleles regulate cortical development Dev Biol 2009 330 2 440 451 19371735
65. Wang Y Kim E Wang X Novitch BG Yoshikawa K Chang LS ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities Cell. 2012 150 4 816 830 22901811
66. Li X Newbern JM Wu Y Morgan-Smith M Zhong J Charron J MEK is a key regulator of gliogenesis in the developing brain Neuron. 2012 75 6 1035 1050 22998872
67. Holter MC Hewitt LT Koebele SV Judd JM Xing L Bimonte-Nelson HA The Noonan syndrome-linked Raf1L613V mutation drives increased glial number in the mouse cortex and enhanced learning PLoS Genet 2019 15 4 e1008108 31017896
68. Bonni A Sun Y Nadal-Vicens M Bhatt A Frank DA Rozovsky I Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway Science. 1997 278 5337 477 483 9334309
69. Ge W Martinowich K Wu X He F Miyamoto A Fan G Notch signaling promotes astrogliogenesis via direct CSL-mediated glial gene activation J Neurosci Res 2002 69 6 848 860 12205678
70. Fukuda S Abematsu M Mori H Yanagisawa M Kagawa T Nakashima K Potentiation of astrogliogenesis by STAT3-mediated activation of bone morphogenetic protein-Smad signaling in neural stem cells Mol Cell Biol 2007 27 13 4931 4937 17452461
71. Gartner U Alpar A Seeger G Heumann R Arendt T Enhanced Ras activity in pyramidal neurons induces cellular hypertrophy and changes in afferent and intrinsic connectivity in synRas mice Int J Dev Neurosci 2004 22 3 165 173 15140470
72. Liu H Jin X Yin X Jin N Liu F Qian W PKA-CREB signaling suppresses tau transcription J Alzheimers Dis 2015 46 1 239 248 25720403
73. Reinhardt P Schmid B Burbulla LF Schondorf DC Wagner L Glatza M Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression Cell Stem Cell 2013 12 3 354 367 23472874
74. Wang X Snape M Klann E Stone JG Singh A Petersen RB Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome J Neurochem 2012 121 4 672 679 22393900
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.